scanance.
Sign inGet Premium
CO

Cencora, Inc.

CORHealthcareNASDAQ

Medical Distribution

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$321.33B
+9.3% YoY
Net Income
$1.55B
+3.0% YoY
EBITDA
$3.75B
+11.1% YoY
Free Cash Flow
-$318.2M

Scan Results

Daily timeframe
DateIndicatorDetails
Loading...
About Cencora, Inc.

Headquartered within the healthcare sector, Cencora, Inc. focuses on Medical Distribution services and products. Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company carries a $51.53B market cap, placing it firmly in the large-cap category.

Key stats
Market Cap$51.53B
P/E (TTM)20.28
Fwd P/E13.37
EPS$13.06
Beta0.65
52W Change-8.4%
Dividend Yield0.91%
ROE107.1%
Analysis

The company holds $2.18B in cash, though total debt stands at $15.09B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company is burning cash, with free cash flow at -$318.2M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Return on equity stands at 107.1%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 3.5% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $238.59B (2022) to $321.33B (2025), reflecting a 35% increase over the period.

With a beta below 0.7, Cencora, Inc. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Cencora, Inc. and its sector.

Links
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms